Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1993 2
2002 1
2005 3
2006 2
2007 3
2008 1
2009 2
2010 1
2011 4
2012 4
2013 6
2014 5
2015 5
2016 2
2017 3
2018 5
2019 2
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial.
Baize N, Monnet I, Greillier L, Geier M, Lena H, Janicot H, Vergnenegre A, Crequit J, Lamy R, Auliac JB, Letreut J, Le Caer H, Gervais R, Dansin E, Madroszyk A, Renault PA, Le Garff G, Falchero L, Berard H, Schott R, Saulnier P, Chouaid C; Groupe Français de Pneumo-Cancérologie 01–13 investigators. Baize N, et al. Among authors: le caer h. Lancet Oncol. 2020 Sep;21(9):1224-1233. doi: 10.1016/S1470-2045(20)30461-7. Lancet Oncol. 2020. PMID: 32888454 Clinical Trial.
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Guigay J, Aupérin A, Fayette J, Saada-Bouzid E, Lafond C, Taberna M, Geoffrois L, Martin L, Capitain O, Cupissol D, Castanie H, Vansteene D, Schafhausen P, Johnson A, Even C, Sire C, Duplomb S, Evrard C, Delord JP, Laguerre B, Zanetta S, Chevassus-Clément C, Fraslin A, Louat F, Sinigaglia L, Keilholz U, Bourhis J, Mesia R; GORTEC; AIO; TTCC, and UniCancer Head and Neck groups. Guigay J, et al. Lancet Oncol. 2021 Apr;22(4):463-475. doi: 10.1016/S1470-2045(20)30755-5. Epub 2021 Mar 5. Lancet Oncol. 2021. PMID: 33684370 Clinical Trial.
Management of elderly patients.
Vergnenegre A, Corre R, Lena H, Le Caer H. Vergnenegre A, et al. Among authors: le caer h. Transl Lung Cancer Res. 2013 Jun;2(3):200-7. doi: 10.3978/j.issn.2218-6751.2013.02.04. Transl Lung Cancer Res. 2013. PMID: 25806233 Free PMC article. Review.
How old is "too old" for translational research?
Vergnenegre A, Corre R, Lena H, Le Caer H. Vergnenegre A, et al. Among authors: le caer h. Transl Lung Cancer Res. 2014 Apr;3(2):116-9. doi: 10.3978/j.issn.2218-6751.2014.03.03. Transl Lung Cancer Res. 2014. PMID: 25806290 Free PMC article. Review.
Treatment of inoperable elderly head and neck cancer patients.
Guigay J, Le Caer H, Ortholan C, Aupérin A, Michel C, Mertens C. Guigay J, et al. Among authors: le caer h. Curr Opin Oncol. 2019 May;31(3):152-159. doi: 10.1097/CCO.0000000000000526. Curr Opin Oncol. 2019. PMID: 30985496 Review.
[Hypofractionad radiotherapy for elderly with head and neck cancer].
Ortholan C, Auperin A, Mertens C, Le Caer H, Guigay J. Ortholan C, et al. Among authors: le caer h. Cancer Radiother. 2018 Oct;22(6-7):640-643. doi: 10.1016/j.canrad.2018.06.008. Epub 2018 Aug 11. Cancer Radiother. 2018. PMID: 30108013 Review. French.
[Pregnancy and lung cancer: a case report and review of the literature].
Montilla F, Le Caer H, Boyer S, Diquelou JY, Amar P, Le Saux S. Montilla F, et al. Among authors: le caer h. J Gynecol Obstet Biol Reprod (Paris). 2008 Dec;37(8):808-10. doi: 10.1016/j.jgyn.2008.05.012. Epub 2008 Jul 21. J Gynecol Obstet Biol Reprod (Paris). 2008. PMID: 18644684 Free article. Review. French.
53 results